Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Improvement of a clinical colorectal cancer risk prediction model integrating polygenic risk.
Authors
Erika Leigh Spaeth Tuff
Phenogen Sciences Inc, Charlotte, NC;
Erika Leigh Spaeth Tuff , Aviv Gafni , Gillian S. Dite , Richard Allman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Prevention, Screening, and Hereditary Cancers
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 81)
DOI
10.1200/JCO.2023.41.4_suppl.81
Abstract #
81
Poster Bd #
D18
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Estimating the impact of reducing the age of colorectal cancer screening on cancer incidence, mortality, and costs in Canada using OncoSim.
First Author: Anastasia Kalyta
Poster
2020 ASCO Virtual Scientific Program
Green tea extract to prevent colorectal adenomas in men and women: Results of the MIRACLE trial.
First Author: Thomas Jens Ettrich
Poster
2019 ASCO Annual Meeting
Aspirin as adjuvant treatment for colorectal cancer: Rationale and progress of the Add-Aspirin trial.
First Author: Ruth E Langley
Poster
2015 ASCO Annual Meeting
Development and external validation of a melanoma risk prediction model using self-assessed risk factors.
First Author: Kylie Vuong